Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.8M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
49.9M
-
Shares change
-
+33.1M
-
Total reported value, excl. options
-
$355M
-
Value change
-
+$245M
-
Number of buys
-
40
-
Number of sells
-
-8
-
Price
-
$7.11
Significant Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q2 2024
50 filings reported holding CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.9M shares
of 67.8M outstanding shares and own 73.65% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (31.4M shares), Deep Track Capital, LP (3.9M shares), Samsara BioCapital, LLC (3.26M shares), JANUS HENDERSON GROUP PLC (3.25M shares), Boxer Capital, LLC (2.6M shares), Affinity Asset Advisors, LLC (1.67M shares), Driehaus Capital Management LLC (696K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (670K shares), Ally Bridge Group (NY) LLC (500K shares), and BlackRock Inc. (382K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.